Aside from the inherent interest in finding out how antibiotics inhibit cell growth, antibiotics can be useful in vivo: (i) as reagents to inhibit protein synthesis at defined steps in the biosynthetic pathway; (ii) to dissociate protein from nucleic acid synthesis, thus facilitating studies on the relationships between nucleic acid and protein synthesis; and (iii) in studies of various aspects of the ribosome cycle. This investigation on the mode and site of action of amicetin was directed toward these ends.
Amicetin, an aminohexosepyrimidine nucleoside antibiotic, inhibits protein synthesis in sensitive cells, and in cell-free extracts derived from these cells (1) . Previous studies have shown that in vitro the antibiotic interacts with the 50S ribosome subunit (3) ; inhibits the puromycin reaction (17) ; inhibits di-and oligophenylalanine synthesis dependent on guanosine triphosphate and factor G (18) ; and inhibits the binding of the phenylalanyl-transfer ribonucleic acid (RNA) oligonucleotide C-A-C-C-A(Phe) to ribosomes (S. Pestka insensitive to the action of the antibiotic; consequently, strains of E. coli were used which were more sensitive to amicetin than was the wild type. A description of the isolation and properties of these strains is given elsewhere (7) . Figure 1 shows the effect of amicetin on protein synthesis in intact cells of the wild type W1895 and the sensitive mutant H135. As can be seen, the mutant is much more sensitive to the antibiotic than the parent.
Effect of amicetin on RNA synthesis. Amicetin at concentrations that completely inhibit protein synthesis had relatively little effect on RNA synthesis (Fig. 2) . These results confirm those of Bloch and Coutsogeorgopoulos (2), who have shown that RNA and deoxyribonucleic acid synthesis continue in the presence of the antibiotic.
Reversibility of amicetin inhibition of protein synthesis. The action of amicetin on protein synthesis was readily reversed by washing the cells free from the drug. In this experiment (Fig. 3) (8), amicetin stabilized polysomes. Amicetin was added to a culture of strain H101 growing at 37 C, and incubation was continued for an additional 15 min. Although protein synthesis was completely inhibited, the polysome content of the cells was preserved (Fig. 4) . These polysomes can be degraded in vitro by the addition of ribonuclease (0.1 ug/ml) in the cold before centrifugation. In this experiment, the cultures were also pulse-labeled with '4C-uracil 30 sec before harvesting. The dashed lines in Fig. 4 indicate the radioactivity associated with the polysomes. It is clear that pulse-labeled RNA can associate with polysomes in drug-treated cells as well as in growing cells. This finding is not unique, since it has already been shown that pulse-labeled RNA enters polysomes in chloramphenicol-treated cells (21) . In another experiment, not shown here, it was also shown that nascent peptide remained attached to ribosomes during amicetin inhibition.
Consequently, amicetin is another addition to the list of drugs which may be useful in studying polysome and messenger RNA metabolism in vivo.
Effect of amicetin on the action of puromycin, synergistin A, and rifampin. The effect of amicetin on the action of a number of antibiotics of known action was also studied.
Puromycin, which inhibits protein synthesis by forming a peptide linkage with the growing peptide chain on the polysomes (11, 14, 15, 20) , causes a rapid breakdown of polysomes (9, 19) . The effect of amicetin on the puromycin-induced breakdown of polysomes in vivo is shown in Fig. 5 . Cells of strain H135 were treated with puromycin (0.2 mm), and samples were taken at intervals and analyzed for polysome content. As can be seen in Fig. 5 , the breakdown of polysomes induced by puromycin was rapid, being complete after 15 sec (which was the earliest sample taken). In contrast to this finding, cells treated with amicetin 5 min before addition of puromycin retained the bulk of their polysomes, although there was a slight continual loss with increasing time of incubation.
Synergistin A and vernamycin A are antibiotics which apparently inhibit protein synthesis by interfering with initiation of protein synthesis (H. L. Ennis and K. E. Duffy, Fed. Proc. 30:1235, 1971), but do not affect elongation (5; Pestka, in press). Experiments similar to the one described in Fig. 5 were done except that Effect of amicetin on RNA synthesis. Cells of strain HIOI were grown in mineral salts-glucose medium containing methionine (100 ,g/ml) and uracil (20 jug/ml). Amicetin (0.4 mM) was added to one culture (-), and the other culture was incubated in the absence of the drug (0). '4C-uracil (0.1 ;&Ci/mI) was added, and samples were taken at the indicated intervals. Incorporation ofradioactivity into RNA was determined as previously described (4) . Growing cells of straini H135 were incubated with amicetin (0.4 mM) for 45 min in a mineral-salts glucose medium. The cells were theni cenitrifuged and washedfree from the druig by two more cycles ofsuspensioni in mineral salts buffer and centrifugation. Finially, the cells were suspended int mineral salts-glucose growth medium, and the incorporation of '4C-leucine into protein was determined at the indicated intervals (0). This is compared to a culture of growing cells at the same cell density maniipulated in the same way as the inihibited culture except that the cells were n1ot previouisly incuibated in the presenice of amicetin (0). synergistin A was used instead of puromycin. Synergistin A (0.2 mM) treatment also resulted in the loss of the majority of intracellular polysomes (Fig. 6) . Since in the presence of synergistin A new proteins are not initiated, the loss of polysomes under this condition is a reflection of the time it takes to finish protein chains already in the process of being synthesized. It is shown in Fig. 6 that amicetin also markedly inhibited the synergistin A-induced breakdown of polysomes. The results obtained with vernamycin A were identical.
Rifampin is an antibiotic that inhibits initiation of new RNA synthesis (12) . Therefore, rifampin can be used to study the loss of intracellular polysomes as a consequence of the normal decay of messenger RNA, uncomplicated by new RNA synthesis. An experiment with rifampin (0.03 mm) was performed in the same way as those described above for puromycin or synergistin A. As has been described by Schlessinger and co-workers (21), rifampin treatment resulted in a rapid loss of polysomes, with a halflife of approximately 2.5 min (Fig. 7) . Pretreatment of cells with amicetin 5 with ethylenediaminetetraacetate (13) and isolation of sensitive mutants (1, 22) Fig. 8 .
The polysomes, in this case, were labeled with 14C-uracil during the growth period. The polysomes were incubated in the in vitro system described in the legend to Fig. 8 Amicetin immediately and completely inhibits incorporation of ["4C] phenylalanine into peptide in a system using polysomes isolated from growing cells of strain H101 (Fig. 8) 100 ,ug; and 14C-phenylalanine, 0.5 ,uCi, 0.002 Mim. The reaction was started by the addition of "C-phenylalanine and was incubated at 37 C. Amicetin (0.4 mM) was added to the mixture 30 sec before the addition of the '4C-phenylalanine. Samples (100 4Aliters) taken at the indicated intervals were mixed with 0.5 ml of trichloroacetic acid, heated at 100 C for 10 min, filtered through membrane filters (0.45 ,um pore size; Millipore Corp.) and counted. Control reactions, no amicetin (0). Reactions in the presence of amicetin (* ).
in vitro as well as in vivo. In addition, amicetin can also inhibit the puromycin-induced breakdown of polysomes in vitro (Table 1) as well as in vivo (Fig. 5) . I have also used this system to study the effects of other antibiotics, and in all instances the in vitro results are the same as those obtained with intact sensitive bacterial cells (in preparation).
